The FTIR has a detection limit of approximately 5%. Substances below this level may not appear in results — even if they are toxic or affect the potency of your sample.
When possible, we may provide a percentage estimate based on what the FTIR detects. These numbers are generated by software and reflect only the visible components — not the full composition of the sample. The FTIR cannot isolate individual substances in complex mixtures, so any percentage estimates are approximate. They may not reflect actual potency, and similar-looking samples can yield different results – therefore we do not provide purity testing. Any percentages we offer are estimates based on the visible ingredients identified through FTIR spectroscopy. Since this method does not account for the entire sample, undetected ingredients below the detection threshold may influence the composition. The percentages are intended only as a general indication of how the identified ingredients are distributed within the sample. Due to this, any percentages provided cannot be used to calculate milligram quantities within a sample. Our results should not be used to determine exact dosages.
Additionally, a sample may not reflect the full composition of a drug. For example, testing part of a pill may not represent the rest. Cross-contamination between samples stored together can also affect results.
When we detect only one substance, we don’t provide a percentage because other ingredients might still be present below the 5% detection limit.
Treat any percentage result as a rough guideline, not a precise measurement.
Tests highlighted in red indicate particularly dangerous or unexpected results. Flagged samples can alslo be viewed on our Alerts page.
We also use test strips to detect the presence of fentanyl, benzodiazapenes, and lysergamide (LSD).
The results provided are strictly for personal use and educational purposes. They must not be published, distributed, or shared publicly in any form. Unauthorized sharing, reproduction, or publication of these results is strictly prohibited and may result in disciplinary action.
If you find our results shared elsewhere, please be aware that such use is unauthorized and we do not condone it. Images or representations of our results can be easily replicated or altered online, potentially containing misleading or false information. We strongly recommend testing your own samples to ensure accuracy and reliability.
The uncertain match in this sample appears to include a propionate of some kind.
Anonymous, BC
02/13/2022
Category: Opioid Brown Granules
Fentanyl
Fentanyl
50-55%
Propionanilide
25-30%
Caffeine
10-15%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Negative
Vancouver, BC
02/13/2022
Category: Opioid Colourless Crystal
Fentanyl
Fentanyl
90-95%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Negative
The uncertain match in this sample may be a fentanyl precursor.
Vancouver, BC
02/13/2022
Category: Opioid Yellow Granules
Fentanyl
Fentanyl
90-95%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Negative
Vancouver, BC
02/13/2022
Category: Opioid Light Brown Pebble
Down
Fentanyl
60-65%
Uncertain Match
35-40%
Fentanyl: Positive Benzodiazepine: Negative
Anonymous, BC
02/13/2022
Category: Opioid Light Brown Granules
Fentanyl
Erythritol
40-45%
Caffeine
35-40%
Fentanyl or analog
5-10%
Uncertain Carbohydrate
5-10%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Negative
Etizolam or a similar substance is suspected in this sample but cannot be confirmed.
Vancouver, BC
02/13/2022
Category: Opioid Yellow Granules
Fentanyl
Erythritol
40-45%
Caffeine
25-30%
Fentanyl
15-20%
Xylazine
5-10%
Uncertain Match
5-10%
Fentanyl: Positive Benzodiazepine: Positive
Client expected fentanyl and xylazine. The combination of xylazine, fentanyl, and benzodiazepines can cause complex overdose situations. Xylazine is a vet sedative not approved for human use.